Home Infusion Therapy Market Size By Product (Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Industry Trends

Home Infusion Therapy Market size was over USD 17 billion in 2018, with an expected forecast of over 9% CAGR from 2019 to 2025.
 

Get more details on this report - Request Free Sample PDF
 

Growing prevalence of hospital acquired infections is one of the major factors that will positively influence the growth of home infusion therapy market. According to European Center for Disease Prevention and Control (ECDC), 4.5 million people suffered from nosocomial infection in 2017. Home infusion therapy considerably reduces the exposure of patients to infectious organisms decreasing the spread of nosocomial diseases by the patients. Moreover, the cost effectiveness of home infusion therapy compared to hospitalization will further boost the industry growth.
 

Various technological advancements and launch of novel products will supplement the industry growth. Introduction of sophisticated technologies in home care settings will provide new treatment options with reduced risks of infections. Moreover, development of smart infusion pumps are able to prevent dosing errors and increases patient safety. Aforementioned factors will drive the market growth across the forecast timeframe.
 

However, lack of reimbursement in developing economies coupled with various risks associated with the irregular functioning of infusion devices and probable chances of incorrect dose administration may hamper business growth in the future.
 

Request 15% Free Customization on this Report
 

By Product

Get more details on this report - Request Free Sample PDF
 

Intravenous (IV) sets segment will reach USD 4.1 billion by 2025. High growth is attributed to various advantages associated with IV sets such as prolonged action, controlled rate of administration. IV sets comprise of needle free Y-sites that reduces risk of needlestick injuries. Moreover, IV sets allow administration of drugs that are non-absorbable via other routes of administration.
 

Intravenous (IV) cannulas segment is forecasted to expand at 9.3% CAGR across the forecast timeframe. Increasing requirement of patients at various homecare for infusion therapies will boost the growth of IV cannulas. Wide array of applications such as use of IV cannulas for blood collection coupled with real-time monitoring of administered medicines. Cannula are also used in surrounding internal and external surface of medicinal needle thereby, this provides extension to needle to approach veins, thus propelling segment growth.
 

By Application

Parenteral nutrition segment will show significant growth rate of 10.3% during the analysis period. High growth rate is due to increasing demand for home healthcare among developed regions of North America and Europe. Moreover, growing prevalence of geriatric population across the globe that have difficulty in taking nutrition via oral route will further boost the growth of parenteral nutrition segment in the future.
 

Hydration therapy segment accounted for market size of USD 385.4 million in 2018. Hydration therapy provides numerous benefits to the patients such as providing additional additives and electrolytes along with elimination of unnecessary hospitalization and outpatient visits or emergency room visits. Furthermore, advancement in technology allows intermittent and continuous administration of home IV hydration therapy, thus fostering business growth.
 

By Region

Get more details on this report - Request Free Sample PDF
 

North America accounted for revenue of USD 7.6 billion in 2018. Increasing prevalence of chronic diseases coupled with rising number of hospital acquired infections (HAI’s). For instance, as per the Centers for Disease Control and Prevention (CDC), in 2015, an estimated 687 thousand people were diagnosed with nosocomial infection in acute care hospitals. Growing prevalence of nosocomial infection coupled with increasing cost of availing healthcare facilities in the U.S. will propel the demand for home infusion therapy across various home healthcare settings in the future.
 

Asia Pacific home infusion therapy market is expected to show robust growth of 10.7% during the projected timeframe. High growth is attributed to growing geriatric population base. For instance, as per the World Bank estimates, in 2018, about 27% of the Japanese population aged above 65 years. Furthermore, companies operating in this segment are focusing their attention towards the developing nations to explore untapped growth avenues, thus fostering regional growth.
 

Competitive Market Share

Major companies operating in home infusion therapy include CareFusion, Baxter, Fresenius Kabi, Smiths Medical, B. Braun, Caesarea Medical Electronics, Terumo and ICU Medical. The industry participants undertake various strategies such as intensive R&D activities for novel product development, mergers and acquisition to strengthen their market position and product portfolio.
 

Recent industry developments:

• In April 2018, Smiths Medical announced launch of CADD-Solis wireless infusion pump that can be used by patients outside hospital facilities as well. This new product launch enabled the company to strengthen its product offering and expand the customer base.
   
• In April 2017, B. Braun announced launch of Easypump Infusion Pump System for patients and healthcare professionals that ensured safe and effective administration of medication. This launch enabled the company to strength its position in the home infusion therapy market.
   

Home Infusion Therapy Industry Background

Infusion therapy involves the administration of medication through a catheter or needle. It is prescribed for patients in critical conditions who are difficult to treat effectively with oral medicines. The home infusion therapy market is highly competitive in nature, with a few major companies and several small local providers. In the beginning of 1996, hospitals took the initiative to develop home care programs for patients in critical conditions. Increasing technological advancements in the home infusion therapy devices will further boost product demand. For instance, infusion pumps used for infusing fluids, nutrients or medication into a patient's circulatory system have evolved significantly in the last decade. It consists of several features and functions to help alert the caretaker about patients’ urgent needs. Additionally, increasing uses of home infusion therapy devices for applications such as chemotherapy, hydration therapy will further augment industry growth in the fourth coming years.